- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
PAN Foundation and Bladder Cancer Advocacy Network Enter Alliance to Support Patients With Bladder Cancer
The Patient Access Network (PAN) Foundation has launched a new alliance with the Bladder Cancer Advocacy Network to offer financial and patient support services for patients with bladder cancer.
The Patient Access Network (PAN) Foundation has launched a new alliance with the Bladder Cancer Advocacy Network to offer financial and patient support services for patients with bladder cancer. Patients who qualify for the program are eligible to receive $3400 a year in financial assistance.
To be eligible, patients must be receiving treatment for bladder cancer; must be living and receiving treatment in the United States; must have Medicare; and their medication must be covered by Medicare and listed on the PAN Foundation's list of covered medications. Read more on the alliance.
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Nathan Walcker Discusses Value-Based Oncology Care Initiatives at FCS
September 8th 2023Nathan Walcker, CEO at Florida Cancer Specialists & Research Institute (FCS), highlights some of the recent partnerships and initiatives at FCS to improve community-based oncology care from a value-based perspective.
Listen
What We’re Reading: New HPV Screenings; Lung Cancer Pills; Migraine Relief Device
November 9th 2023A study suggests that human papillomavirus (HPV) screenings should be updated due to effective HPV vaccines; a new study shows that osimertinib (Tagrisso, AstraZeneca) reduced both the 5-year risk of recurrent cancer and the risk of death in patients with stage 1B to 3A lung cancer; a new smartphone-controlled technology could help those who suffer from migraines.
Read More
